Tandem Diabetes Care (TNDM) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to -$319.1 million.
- Tandem Diabetes Care's Enterprise Value rose 3257.81% to -$319.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$319.1 million, marking a year-over-year increase of 3257.81%. This contributed to the annual value of -$438.3 million for FY2024, which is 632.23% up from last year.
- Per Tandem Diabetes Care's latest filing, its Enterprise Value stood at -$319.1 million for Q3 2025, which was up 3257.81% from -$315.4 million recorded in Q2 2025.
- In the past 5 years, Tandem Diabetes Care's Enterprise Value registered a high of -$315.4 million during Q2 2025, and its lowest value of -$635.4 million during Q1 2022.
- For the 5-year period, Tandem Diabetes Care's Enterprise Value averaged around -$505.4 million, with its median value being -$507.2 million (2023).
- Per our database at Business Quant, Tandem Diabetes Care's Enterprise Value tumbled by 22048.15% in 2021 and then skyrocketed by 3257.81% in 2025.
- Tandem Diabetes Care's Enterprise Value (Quarter) stood at -$623.8 million in 2021, then grew by 1.11% to -$616.9 million in 2022, then increased by 24.15% to -$467.9 million in 2023, then grew by 6.32% to -$438.3 million in 2024, then grew by 27.2% to -$319.1 million in 2025.
- Its Enterprise Value stands at -$319.1 million for Q3 2025, versus -$315.4 million for Q2 2025 and -$368.6 million for Q1 2025.